We offer a complete range of services, from cell line and strain development through process development and large-scale manufacturing to fill and finish. Our extensive portfolio of capabilities and technologies includes the production of antibodies, recombinant proteins, non-antibody scaffolds, Fab fragments as well as pDNA from either mammalian cell culture or microbial fermentation systems.
Over the past 35 years we have repeatedly converted promising product ideas into commercial reality on a global scale.
- We are your alternative to risky capital investments for moving into production capacity.
- We help you flexibly manage demand uncertainties.
- We offer manufacturing excellence in a cost-effective way.
- We give you the freedom to focus on your own strategic priorities.